Outbreaks of human monkeypox after cessation of smallpox vaccination

被引：152

作者：

Reynolds, Mary G. ^{[1
]}

Damon, Inger K. ^{[1
]}

机构：

[1] US Ctr Dis Control & Prevent, Div High Consequence Pathogens & Pathol, Atlanta, GA 30333 USA

来源：

TRENDS IN MICROBIOLOGY | 2012年 / 20卷 / 02期

关键词：

monkeypox; smallpox vaccine; emerging infectious disease; immune evasion; ecological niche; Congo Basin; PROTECTS NONHUMAN-PRIMATES; MODIFIED VACCINIA VIRUS; DNA VACCINE; LETHAL MONKEYPOX; CONGO BASIN; AFRICAN STRAINS; NORTH-AMERICAN; UNITED-STATES; WEST-AFRICAN; RISK-FACTORS;

D O I：

10.1016/j.tim.2011.12.001

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

The recent observation of a surge in human monkeypox in the Democratic Republic of the Congo (DRC) prompts the question of whether cessation of smallpox vaccination is driving the phenomenon, and if so, why is re-emergence not universal throughout the historic geographic range of the virus? Research addressing the virus's mechanisms for immune evasion and induction, as well as that directed at elucidating the genes involved in pathogenesis in different viral lineages (West African vs Congo Basin), provide insights to help explain why emergence appears to be geographically limited. Novel vaccines offer one solution to curtail the spread of this disease.

引用

页码：80 / 87

页数：8

共 74 条

[1] HUMAN MONKEYPOX - A NEWLY EMERGED ORTHOPOXVIRUS ZOONOSIS IN THE TROPICAL RAIN FORESTS OF AFRICA
ARITA, I
JEZEK, Z
KHODAKEVICH, L
RUTI, K
[J]. AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 1985, 34 (04) : 781 - 789
[2] Arita I, 1984, B WORLD HEALTH ORGAN, V62, P703
[3] HUMAN POXVIRUS DISEASE AFTER SMALLPOX ERADICATION
BREMAN, JG
NAKANO, JH
COFFI, E
GODFREY, H
GAUTUN, JC
[J]. AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 1977, 26 (02) : 273 - 281
[4] A protein-based smallpox vaccine protects non-human primates from a lethal monkeypox virus challenge
Buchman, George W.
Cohen, Matthew E.
Xiao, Yuhong
Richardson-Harman, Nicola
Silvera, Peter
DeTolla, Louis J.
Davis, Heather L.
Eisenberg, Roselyn J.
Cohen, Gary H.
Isaacs, Stuart N.
[J]. VACCINE, 2010, 28 (40) : 6627 - 6636
[5] Virulence differences between monkeypox virus isolates from West Africa and the Congo basin
Chen, NH
Li, GY
Liszewski, MK
Atkinson, JP
Jahrling, PB
Feng, ZH
Schriewer, J
Buck, C
Wang, CL
Lefkowitz, EJ
Esposito, JJ
Harms, T
Damon, IK
Roper, RL
Upton, C
Buller, RML
[J]. VIROLOGY, 2005, 340 (01) : 46 - 63
[6] Discovery of monkeypox in Sudan
Damon, Inger K.
Roth, Cathy E.
Chowdhary, Vipul
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 2006, 355 (09) : 962 - 963
[7] The highly virulent variola and monkeypox viruses express secreted inhibitors of type I interferon
del Mar Fernandez de Marco, Maria
Alejo, Ali
Hudson, Paul
Damon, Inger K.
Alcami, Antonio
[J]. FASEB JOURNAL, 2010, 24 (05) : 1479 - 1488
[8] Retrospective analysis of monkeypox infection
Dubois, Melissa E.
Slifka, Mark K.
[J]. EMERGING INFECTIOUS DISEASES, 2008, 14 (04) : 592 - 599
[9] Recombinant modified vaccinia virus Ankara provides durable protection against disease caused by an immunodeficiency virus as well as long-term immunity to an orthopoxvirus in a non-human primate
Earl, Patricia L.
Americo, Jeffrey L.
Wyatt, Linda S.
Eller, Leigh Anne
Montefiori, David C.
Byrum, Russ
Piatak, Michael
Lifson, Jeffrey D.
Amara, Rama Rao
Robinson, Harriet L.
Huggins, John W.
Moss, Bernard
[J]. VIROLOGY, 2007, 366 (01) : 84 - 97
[10] Immunogenicity of a highly attenuated MVA smallpox vaccine and protection against monkeypox
Earl, PL
Americo, JL
Wyatt, LS
Eller, LA
Whitbeck, JC
Cohen, GH
Eisenberg, RJ
Hartmann, CJ
Jackson, DL
Kulesh, DA
Martinez, MJ
Miller, DM
Mucker, EM
Shamblin, JD
Zwiers, SH
Huggins, JW
Jahrling, PB
Moss, B
[J]. NATURE, 2004, 428 (6979) : 182 - 185

← 1 2 3 4 5 6 7 8 →